Research Group receive Innovate UK ICURe SETsquared Award
We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape.
Our Research Associate Simon Porter is currently undertaking these activities remotely via conference attendance and engagement.
Further information on the programme can be found at the link below:
Our peptide hydrogel research wins Controlled Release Society’s 2020 People’s Choice Award
We are excited to hear our research on the use of peptide hydrogels for HIV/AIDs drug delivery won the overall CRS People’s Choice Award at the recent CRS virtual meeting. The presentation, as well as our other work, is available to conference participants by clicking the relevant title below. Poster: Poster number 63. Peptide-like […]
Latest hydrogel work published in Chemical Communications
Our latest collaborative work on entitled “Tuning the antimicrobial activity of low molecular weight hydrogels using dopamine autoxidation,” has been accepted within Chemical Communications. This work was led by Emily Cross and represents a collaboration with Prof Dave Adams’ Group at the School of Chemistry University of Glasgow and is freely available here. Thanks again […]
Latest publication: Pharmaceutical formulation and characterization of dipeptide nanotubes for drug delivery applications
Our latest paper has been published in the journal Macromolecular Bioscience focusing on formulating peptide nanotubes using mild techniques to improve potential for pharmaceutical upscale. Paper can be accessed here: https://doi.org/10.1002/mabi.202000115 Abstract Peptide nanotubes are promising materials for a variety of biomedical applications with ultrashort (≤7 amino acids) forms providing particular promise for clinical translation. […]
Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy
We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery. Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at […]
Our book, Hydrogels: Design, synthesis & application in drug delivery & regenerative medicine, available now!
If you are interested in knowing more about the potential applications of our hydrogels, remember to check out our recent book “Hydrogels: Design, synthesis & application in drug delivery & regenerative medicine,” co-edited alongside Dr Raj Thakur and Prof Ryan Donnelly. Thanks to all those who contributed.
Available Research Fellow Position
Research Fellow positions We are looking for a Research Fellow to support the development of an enzyme-responsive peptide-mimetic hydrogel for the sustained parenteral delivery of antiretroviral drugs for HIV/AIDs. This is an MRC funded project with support available for a one year post (until 30 June 2021). Deadline: Monday 15th June 2020 Salary: £33,797 – […]
Latest paper from group: Investigating the In Vivo Antimicrobial Activity of a Self-Assembling Peptide Hydrogel Using a Galleria mellonella Infection Model
Our latest research paper is now freely available via the journal ACS Omega, whereby we use an innovative waxworm (Galleria mellonella) model as an alternative to mammalian/vertebrate testing. The following assay can be very simply performed without any specific ethical approval or animal licenses. We successfully employed the methods outlined to study the antimicrobial efficacy […]
We will be presenting at the 12th Global Drug Delivery & Formulation Virtual Summit 2021: 17th March 2021
Garry will be presenting an oral presentation, entitled Peptide Nanomaterials: The Future of Biomaterials and Drug Delivery, at 12th Global Drug Delivery & Formulation Virtual Summit 2021: Wednesday 17th March 2021 (11.50am Technology & Innovation case study section). Hopefully you will have to opportunity look see our latest work within drug delivery! Further details on the […]